Category: IBBJ

The Launch of Nasdaq Junior Biotech

The Nasdaq Junior Biotechnology Index (NBIJR) was launched on April 30, 2020, in the midst of the Coronavirus pandemic, perhaps the most consequential backdrop imaginable for the overall Biotech industry. NBIJR’s methodology is rather straightforward, taking the existing membership of the Nasdaq Biotechnology Index (NBI) and limiting constituents by placing a cap on market capitalization...

Read More
Category: IBBJ

Defiance ETFs Rings The Nasdaq Closing Bell

Defiance ETFs, a thematic ETF company built for the next generation of investors, rang the Nasdaq Closing Bell remotely from across the country. Paul Dellaquila, President, rang the Closing Bell in a virtual bell ringing ceremony. View the original video at Nasdaq.com 

Read More
Category: IBBJ

ETF of the Week: Defiance Nasdaq Junior Biotechnology ETF (IBBJ)

ETF Trends CEO Tom Lydon discussed the Defiance Nasdaq Junior Biotechnology ETF (IBBJ) on this week’s “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show. IBBJ covers companies around the globe that are focused on various areas within the biotech or pharmaceuticals space. Included companies are those involved in genomics, DNA technology, genetic engineering, and molecular bi...

Read More
Category: IBBJ

Junior Biotech ETF Debuts

Today, Defiance ETFs launched a third ETF, this one with a focus on small cap biotechnology companies. The Defiance Nasdaq Junior Biotechnology ETF (IBBJ) tracks an index of roughly 200 U.S. biotech companies that fall within the bottom 10% of the Nasdaq Global Index in terms of size. The fund comes with a expense ratio of 0.45% and lists on the Nasdaq stock exchange. “At Defiance, we be...

Read More
Category: IBBJ

Defiance Debuts Nasdaq Junior Biotechnology ETF (IBBJ)

Defiance ETFs debuted a new ETF today with targeted exposure to the junior disruptors in the biotech space. Defiance ETFs LLC announced the launch of the Defiance Nasdaq Junior Biotechnology ETF (IBBJ), which tracks the Nasdaq Junior Biotechnology Index, offering investors exposure to “junior” companies with a market capitalization below $5 billion. “At Defiance, we believe in providing ...

Read More
Category: IBBJ

Hey, Junior: New Biotech ETF Goes Small In Search Of Big Winners

With significant help from the fight against the Coronavirus, biotechnology stock and exchange-traded funds are setting torrid paces this year. What happened: This year notwithstanding, one thing the biotechnology space has a history of is small stocks providing jaw-dropping gains. Even with that compelling history, only a small number of ETFs provide adequate exposure to small- and mid-...

Read More

Want to work with us?

A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart. I am alone, and feel the charm of existence in this spot.

Contact us